| Product Code: ETC7734537 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Industry Life Cycle |
3.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Porter's Five Forces |
3.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By ACE Inhibitors, 2021 & 2031F |
3.7 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney disease (CKD) in Japan |
4.2.2 Growing awareness about the importance of managing CKD-MBD |
4.2.3 Technological advancements in treatment options for CKD-MBD |
4.3 Market Restraints |
4.3.1 High costs associated with CKD-MBD treatment |
4.3.2 Limited access to specialized healthcare facilities for CKD patients in Japan |
5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Trends |
6 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Types |
6.1 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Medications And Supplements, 2021- 2031F |
6.1.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Dialysis, 2021- 2031F |
6.1.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.6 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Diet, 2021- 2031F |
6.1.7 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.8 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By ACE Inhibitors |
6.2.1 Overview and Analysis |
6.2.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By B-blockers, 2021- 2031F |
6.2.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.2.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Loop Diuretics, 2021- 2031F |
6.2.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Erythropoiesis-Stimulating Agents (ESAs), 2021- 2031F |
6.2.6 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.2.7 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Ambulatory Surgical Centres, 2021- 2031F |
6.4.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Import-Export Trade Statistics |
7.1 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Export to Major Countries |
7.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Imports from Major Countries |
8 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Key Performance Indicators |
8.1 Average time from CKD diagnosis to initiation of MBD treatment |
8.2 Patient adherence rate to prescribed treatment regimens |
8.3 Percentage of CKD patients achieving recommended mineral bone disorder biomarker levels |
9 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Opportunity Assessment |
9.1 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By ACE Inhibitors, 2021 & 2031F |
9.3 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Competitive Landscape |
10.1 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 Japan Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here